Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

When Is FDG-PET Useful After Negative MRI and Antibodies?

At a Glance

FDG-PET may support the evaluation of suspected seronegative autoimmune encephalitis when MRI and antibody tests are unrevealing by showing abnormal brain glucose metabolism. It is not definitive: normal results do not exclude the disease, and abnormal patterns can have other causes.

An FDG-PET scan is sometimes considered by specialists when a patient’s symptoms strongly point to autoimmune encephalitis (AE), but standard tests—like an MRI and antibody panels—are unrevealing [1]. In these diagnostically ambiguous cases, an FDG-PET scan acts as a supportive investigation [2]. In seronegative (antibody-negative) AE, standard testing does not find one of the known disease-causing antibodies [3]. However, a negative blood test does not prove the absence of antibodies—comprehensive testing should ideally check both blood (serum) and spinal fluid (CSF) [3]. While an FDG-PET scan cannot definitively prove the presence of seronegative AE, it may reveal abnormal patterns of brain activity that help the medical team support their clinical suspicion [4].

Important Safety Context: A PET scan is an outpatient procedure and is not meant to delay urgent medical evaluation. Symptoms such as rapidly worsening confusion, new or prolonged seizures, severe agitation, or vital sign instability typically require emergency care. Doctors can and often do make treatment decisions based on the clinical picture and standard tests without waiting for a PET scan.

How an FDG-PET Scan Works and What to Expect

While an MRI takes detailed pictures of the brain’s physical structure, an FDG-PET (Fluorodeoxyglucose-Positron Emission Tomography) scan looks at how the brain is functioning by measuring glucose metabolism [5].

What happens on the day: Patients are typically asked to fast and monitor their blood sugar before the scan. At the imaging center, a small amount of a radioactive sugar tracer is injected into the bloodstream [5]. The patient then rests quietly in a dim room for about 30 to 60 minutes while the brain absorbs the tracer. Afterward, the scan itself takes about 15 to 30 minutes.

Because the brain relies on glucose for energy, the PET scan highlights areas using abnormal amounts of fuel:

  • Hypermetabolism: Areas using abnormally high amounts of glucose. This can indicate active inflammation, but it can also be caused by recent seizures [5][6].
  • Hypometabolism: Areas using abnormally low amounts of glucose, which can suggest decreased brain function, tissue damage, or suppressed activity [5].

What Can FDG-PET Show When MRI is Normal?

It is common for people with autoimmune encephalitis to have a completely normal MRI [7]. Because FDG-PET looks at function rather than structure, it can sometimes detect metabolic abnormalities that an MRI misses [1]. For example, in one specific study of 30 patients with suspected AE who had a normal MRI, the PET scan showed abnormalities in 23 of them [1]. This does not mean PET will find an answer for everyone, but it highlights its potential as an additional tool.

When abnormalities are found in antibody-negative patients, they often involve reported but nonspecific patterns, such as:

  • Hypermetabolism in the medial temporal lobes (memory centers) or basal ganglia (deep movement centers) [8][4].
  • Hypometabolism in the outer layers (cortex) of the frontal, parietal, or occipital lobes [9][8].

A Complementary Tool, Not a Replacement

Seronegative AE is not simply a diagnosis of exclusion. It requires a compatible set of subacute symptoms, supportive clinical findings, and the reasonable exclusion of other diseases [10]. FDG-PET complements standard tests but never replaces them [7]:

  • MRI is usually recommended to rule out tumors, strokes, or structural damage, though a normal result does not exclude AE [7].
  • Lumbar Puncture (CSF analysis) evaluates for inflammation and infections [7]. Just like an MRI, a normal CSF result does not entirely rule out AE.
  • EEG (Electroencephalogram) checks for hidden seizures. A routine EEG might miss intermittent issues, so a prolonged or video EEG is often needed [7].

Limitations and Practical Considerations

If a doctor recommends a PET scan, it is important to discuss these limitations:

  • Nonspecific Results: Abnormal metabolic patterns are not a unique signature for AE. Seizures, neurodegenerative conditions, sedating medications, and recent immunotherapy can all cause similar patterns [8][6].
  • Radiation Exposure: The radioactive tracer itself exposes the patient to a small amount of radiation. This is often combined with a CT scan (PET/CT) for structural reference, adding more radiation. Some centers offer PET/MRI, which avoids the CT radiation, though the tracer radiation remains [11].
  • Cost and Availability: FDG-PET scans can be expensive, generally require insurance pre-authorization, and are mostly available at specialized tertiary medical centers [12].
  • False Negatives: A normal PET scan does not definitively rule out autoimmune encephalitis, as test sensitivity varies depending on the timing of the scan and the patient’s specific condition [13].

Common questions in this guide

Can FDG-PET help if my MRI is normal and antibody tests are negative?
It may show abnormal brain glucose metabolism that a structural MRI does not detect, so it can support a clinician’s suspicion of autoimmune encephalitis. It cannot confirm the diagnosis on its own, and the result must be interpreted with symptoms, spinal-fluid findings, EEG, and other tests.
Does a negative antibody test rule out seronegative autoimmune encephalitis?
No. Seronegative means that standard testing did not detect one of the known disease-associated antibodies; it does not by itself prove that autoimmune encephalitis is absent. Testing both blood and spinal fluid may provide a more complete assessment, while diagnosis also depends on the clinical picture and exclusion of other illnesses.
What does an FDG-PET scan measure in suspected autoimmune encephalitis?
It measures how much glucose different brain areas use, which reflects brain activity. Higher-than-usual activity may occur with inflammation or after a seizure, while lower activity can reflect reduced function or tissue injury. These patterns are not unique to autoimmune encephalitis.
Can seizures or medicines change an FDG-PET result?
Yes. Recent seizures, sedating medicines, neurodegenerative conditions, and recent immune-based treatment can produce metabolic patterns that resemble or obscure autoimmune inflammation. Tell the medical team about seizures, medication changes, and recent treatments so they can interpret the scan in context.
Does a normal FDG-PET scan exclude autoimmune encephalitis?
No. PET sensitivity varies with scan timing and the patient’s specific condition, so a normal result cannot definitively rule out autoimmune encephalitis. Doctors combine PET, MRI, spinal-fluid analysis, EEG, symptoms, and examination findings rather than relying on one test.
What other tests are important when MRI and antibody testing are unrevealing?
A lumbar puncture can check spinal fluid for inflammation and infection, and an EEG can look for seizures that may not be obvious. A prolonged or video EEG may be useful when a routine EEG misses intermittent activity. FDG-PET is an additional tool, not a replacement for these evaluations.
Should I wait for an outpatient PET scan if my symptoms are worsening?
No. Rapidly worsening confusion, new or prolonged seizures, severe agitation, or unstable vital signs need urgent medical assessment. FDG-PET is an outpatient supportive test and should not delay emergency care.

Get notified when new evidence is published on Non-specific autoimmune supratentorial encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Role of FDG PET/CT in definitive and presumed autoimmune encephalitis.

    Kalra S, Tripathi M, Tripathi M, et al.

    Nuclear medicine communications 2024; (45(2)):121-127 doi:10.1097/MNM.0000000000001790.

    PMID: 37982572
  2. 2

    Diagnosing autoimmune encephalitis in psychiatry: clinical recommendations and unresolved challenges from the GENERATE network.

    Endres D, von Zedtwitz K, Tebartz van Elst L, et al.

    Molecular psychiatry 2026; doi:10.1038/s41380-026-03871-2.

    PMID: 42786262
  3. 3

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  4. 4

    18F-FDG PET/CT Metabolic Patterns in Clinically Probable Seronegative Autoimmune Encephalitis with Normal MRI Findings: A Retrospective Observational Study.

    Verma P, Sitani K, Kulkarni S, et al.

    Journal of nuclear medicine technology 2026; doi:10.2967/jnmt.126.272364.

    PMID: 42838617
  5. 5

    18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's Disease.

    Bouter C, Henniges P, Franke TN, et al.

    Frontiers in aging neuroscience 2018; (10()):425 doi:10.3389/fnagi.2018.00425.

    PMID: 30670962
  6. 6

    Comparison of 18F-DPA714 PET/MRI and 18F-FDG PET/CT in patients with autoimmune encephalitis: a cross-sectional study.

    Meng H, Chen X, He L, et al.

    European journal of nuclear medicine and molecular imaging 2025; (52(11)):4292-4307 doi:10.1007/s00259-025-07305-z.

    PMID: 40317304
  7. 7

    Diagnosing autoimmune encephalitis in a real-world single-centre setting.

    Giordano A, Fazio R, Gelibter S, et al.

    Journal of neurology 2020; (267(2)):449-460 doi:10.1007/s00415-019-09607-3.

    PMID: 31667626
  8. 8

    Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study.

    Rostand H, Kuijper FM, Birzu C, et al.

    European journal of nuclear medicine and molecular imaging 2026; doi:10.1007/s00259-026-08111-x.

    PMID: 42584478
  9. 9

    Quantitative brain 18F-FDG PET/CT analysis in seronegative autoimmune encephalitis.

    Roman SN, Sadaghiani MS, Diaz-Arias LA, et al.

    Annals of clinical and translational neurology 2024; (11(5)):1211-1223 doi:10.1002/acn3.52035.

    PMID: 38453690
  10. 10

    Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria.

    Van Steenhoven RW, de Vries JM, Bruijstens AL, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(6)) doi:10.1212/NXI.0000000000200148.

    PMID: 37582614
  11. 11

    Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [18F]FDG PET/CT and [18F]FDG PET/MRI.

    Guberina N, Gäckler A, Grueneisen J, et al.

    Nuclear medicine and molecular imaging 2020; (54(4)):183-191 doi:10.1007/s13139-020-00648-5.

    PMID: 32831964
  12. 12

    Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis.

    Probasco JC, Solnes L, Nalluri A, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2017; (4(4)):e352 doi:10.1212/NXI.0000000000000352.

    PMID: 28567435
  13. 13

    Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis.

    Bordonne M, Chawki MB, Doyen M, et al.

    European journal of nuclear medicine and molecular imaging 2021; (48(12)):3847-3858 doi:10.1007/s00259-021-05299-y.

    PMID: 33677643

This page explains how FDG-PET may support evaluation of suspected seronegative autoimmune encephalitis for informational purposes only and does not constitute medical advice or a diagnosis. Rapidly worsening confusion, prolonged seizures, severe agitation, or unstable vital signs require urgent medical evaluation rather than waiting for an outpatient scan.